FCF Grants Awarded in 2024
Total grants: 5
- Development and implementation of 3D in vitro fibrolamellar carcinoma tumor models — Principal investigator(s): Aleksander Skardal — Ohio State University
- FLC Research Data Initiative — Velsera
- FusionVAC22_02: DNAJB1-PRKACA fusion transcript-based peptide vaccine for fibrolamellar hepatocellular carcinoma patients — Principal investigator(s): Juliane S. Walz — University Hospital Tübingen
- X-Chem collaborative effort — X-Chem
- Targeting CDK7 in Fibrolamellar Carcinoma (FLC) — Principal investigator(s): Sean Ronnekleiv-Kelly — University of Wisconsin
This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded in 2024. The name of the grant is listed, along with the institution receiving the grant and the principal investigator.